Additive prognosis of clinical presentation in revascularized peripheral arterial disease patients.


Journal

Minerva cardiology and angiology
ISSN: 2724-5772
Titre abrégé: Minerva Cardiol Angiol
Pays: Italy
ID NLM: 101776555

Informations de publication

Date de publication:
Aug 2022
Historique:
pubmed: 18 6 2021
medline: 5 8 2022
entrez: 17 6 2021
Statut: ppublish

Résumé

Peripheral artery disease (PAD) is a frequent cause of morbidity and mortality. It may present with diverse clinical presentations. The aim of this study was to evaluate the prognosis of these clinical presentations. We performed a retrospective cohort study, in which symptomatic PAD patients were included from 2014 to 2020 at a university hospital in Argentina. We classified symptomatic PAD in intermittent claudication (IC), chronic limb-threatening ischemia (CLTI) and acute ischemia (AI). Our primary endpoint was to compare the composite of all-cause mortality and major amputation events between the three groups. We included 309 patients, with a median follow up of 1.87 years (IQR 0.72-3.67). The primary endpoint was more prevalent in CLTI and AI patients (33% and 33.3%) compared to IC patients (8.1%), P<0.001. CLTI and AI were independently associated with the primary endpoint after adjusting for clinical variables of interest (OR 4.04 95%CI [1.86-9.07], P<0.001 and OR 5.40 95%CI [2.18-13.7], P<0.001, respectively). Mortality incidence rate (per 100 patients/year) was similar between AI and CLTI patients (14.2 95% CI [8.0-24.1] and 13.1 95%CI [8.8-19.7], respectively, P=0.67) but higher compared to IC (2.9 95%CI [1.6-5.1], P<0.01). Major amputation events were more prevalent in CLTI (16.5%) compared to AI (8.9%) and IC patients (1.2%), P<0.01. Those with CLTI and AI have a particular increased risk of all-cause death and major amputation events. Although mortality incidence was similar between AI and CLTI patients, the latter have an increased risk of major amputation events compared to AI and IC patients.

Sections du résumé

BACKGROUND BACKGROUND
Peripheral artery disease (PAD) is a frequent cause of morbidity and mortality. It may present with diverse clinical presentations. The aim of this study was to evaluate the prognosis of these clinical presentations.
METHODS METHODS
We performed a retrospective cohort study, in which symptomatic PAD patients were included from 2014 to 2020 at a university hospital in Argentina. We classified symptomatic PAD in intermittent claudication (IC), chronic limb-threatening ischemia (CLTI) and acute ischemia (AI). Our primary endpoint was to compare the composite of all-cause mortality and major amputation events between the three groups.
RESULTS RESULTS
We included 309 patients, with a median follow up of 1.87 years (IQR 0.72-3.67). The primary endpoint was more prevalent in CLTI and AI patients (33% and 33.3%) compared to IC patients (8.1%), P<0.001. CLTI and AI were independently associated with the primary endpoint after adjusting for clinical variables of interest (OR 4.04 95%CI [1.86-9.07], P<0.001 and OR 5.40 95%CI [2.18-13.7], P<0.001, respectively). Mortality incidence rate (per 100 patients/year) was similar between AI and CLTI patients (14.2 95% CI [8.0-24.1] and 13.1 95%CI [8.8-19.7], respectively, P=0.67) but higher compared to IC (2.9 95%CI [1.6-5.1], P<0.01). Major amputation events were more prevalent in CLTI (16.5%) compared to AI (8.9%) and IC patients (1.2%), P<0.01.
CONCLUSIONS CONCLUSIONS
Those with CLTI and AI have a particular increased risk of all-cause death and major amputation events. Although mortality incidence was similar between AI and CLTI patients, the latter have an increased risk of major amputation events compared to AI and IC patients.

Identifiants

pubmed: 34137242
pii: S2724-5683.21.05704-5
doi: 10.23736/S2724-5683.21.05704-5
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

413-420

Auteurs

Fernando Garagoli (F)

Department of Cardiology, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina - fernando.garagoli@hospitalitaliano.org.ar.

Juan G Chiabrando (JG)

Department of Interventional Cardiology, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina.

Maria M Abraham Foscolo (MM)

Department of Cardiology, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina.

Giuliana Corna (G)

Department of Cardiology, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina.

Maria M Fleitas (MM)

Department of Cardiology, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina.

Juan Valle Raleigh (J)

Department of Interventional Cardiology, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina.

Horacio Medina DE Chazal (H)

Department of Interventional Cardiology, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina.

José G Chas (JG)

Department of Digital Angiography, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina.

Daniel H Berrocal (DH)

Department of Interventional Cardiology, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina.

José M Rabellino (JM)

Department of Digital Angiography, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina.

Ignacio M Bluro (IM)

Department of Cardiology, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH